Albireo to Present at 19th Annual Rodman & Renshaw Global Investment Conference
BOSTON, Sept. 05, 2017 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq:ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced that Paresh Soni, MD, PhD, Chief Medical Officer, is scheduled to …